VPS72 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.836400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.173800E-01
Normal-vs-Stage2
9.469800E-01
Normal-vs-Stage3
5.311000E-01
Normal-vs-Stage4
3.568200E-01
Stage1-vs-Stage2
9.487200E-01
Stage1-vs-Stage3
5.139800E-01
Stage1-vs-Stage4
2.670200E-01
Stage2-vs-Stage3
2.835600E-01
Stage2-vs-Stage4
1.039440E-01
Stage3-vs-Stage4
2.053000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.938600E-01
Normal-vs-AfricanAmerican
4.664200E-01
Normal-vs-Asian
3.741400E-01
Caucasian-vs-AfricanAmerican
5.585800E-02
Caucasian-vs-Asian
5.308000E-02
AfricanAmerican-vs-Asian
7.309800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.058600E-01
Normal-vs-Female
8.567800E-01
Male-vs-Female
2.481600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.967400E-01
Normal-vs-Age(41-60Yrs)
8.302600E-01
Normal-vs-Age(61-80Yrs)
8.995400E-01
Normal-vs-Age(81-100Yrs)
9.337800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.211000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.956600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.897200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.485400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.845200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.135800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.191000E-01
Normal-vs-Daily Drinker
5.624600E-01
Normal-vs-Weekly Drinker
6.393800E-01
Normal-vs-Occasional Drinker
3.403800E-01
Normal-vs-Social Drinker
5.752200E-01
Non Drinker-vs-Daily Drinker
4.345400E-01
Non Drinker-vs-Weekly Drinker
3.690600E-01
Non Drinker-vs-Occasional Drinker
5.108500E-02
Non Drinker-vs-Social Drinker
5.942400E-01
Daily Drinker-vs-Weekly Drinker
7.254000E-02
Daily Drinker-vs-Occasional Drinker
4.776100E-03
Daily Drinker-vs-Social Drinker
7.361000E-01
Weekly Drinker-vs-Occasional Drinker
3.145600E-01
Weekly Drinker-vs-Social Drinker
1.088850E-01
Occasional Drinker-vs-Social Drinker
1.201820E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.256600E-01
Normal-vs-Grade 2
5.538600E-01
Normal-vs-Grade 3
5.209800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.854800E-01
Grade 1-vs-Grade 3
4.246600E-01
Grade 1-vs-Grade 4
2.256600E-01
Grade 2-vs-Grade 3
3.438200E-01
Grade 2-vs-Grade 4
5.538600E-01
Grade 3-vs-Grade 4
5.209800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.885800E-01
Normal-vs-NonDiabetic
8.001400E-01
Diabetic-vs-NonDiabetic
6.342100E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.618800E-01
Normal-vs-NoPancreatitis
9.942400E-01
Pancreatitis-vs-NoPancreatitis
7.353200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.743800E-01
Normal-vs-N1
8.443600E-01
N0-vs-N1
2.866500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.321800E-01
Normal-vs-TP53-NonMutant
9.768600E-01
TP53-Mutant-vs-TP53-NonMutant
1.340100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
